New scoring methodology improves the sensitivity of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials.

Alzheimers Res Ther · 2015 · PMC4642693 · PMID 26560146

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

In addition, the clinical trial of huperzine A, which detected a marginally significant treatment effect [ 18 ], was used exclusively to evaluate the sensitivity of the new scoring methodology in a real clinical trial scenario.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.